Search results for " anestesiologia"

showing 10 items of 158 documents

A Randomized-Controlled Study of Intrathecal Versus Epidural Thoracic Analgesia in Patients Undergoing Abdominal Cancer Surgery

2008

Background. We sought to determine the effectiveness of continuous intrathecal thoracic analgesia (ITA) in comparison with continuous epidural thoracic analgesia (ETA) for the management of postoperative pain after abdominal cancer surgery in a randomised controlled study. Materials and methods. Catheters were inserted at T8-10 level for both techniques. Sixty patients were randomized to receive ITA providing levobupivacaine 0.25%, at 0.5-0-7 ml/h, associated with a single bolus of morphine 0.15 mg, or ETA with levobupivacaine 0.25% 4-6 ml/h and a single bolus of epidural morphine 2-3 mg. Data were collected before discharging from recovery room to the surgical ward, 1, 2, 3, 8, 12, 24 h, a…

AdultMalemedicine.medical_specialtyResuscitationAdolescentabdominal cancer surgerySettore MED/41 - AnestesiologiaDiuresisHemodynamicsHealth Informaticsepidural analgesiaintrathecal analgesiapostoperative painCritical Care and Intensive Care Medicineintrathecal analgesialaw.inventionYoung AdultRandomized controlled triallawIntensive careAnesthesiologymedicineHumansAnesthetics LocalInjections SpinalAgedPain MeasurementAged 80 and overPain Postoperativebusiness.industryLidocaineepidural analgesiaMiddle AgedSurgeryAnalgesia EpiduralTreatment OutcomeAnesthesiology and Pain MedicineLevobupivacaineAbdominal NeoplasmsAnesthesiaMorphineFemalebusinessmedicine.drugJournal of Clinical Monitoring and Computing
researchProduct

European Resuscitation Council Guidelines 2021: Adult advanced life support.

2021

These European Resuscitation Council Advanced Life Support guidelines, are based on the 2020 International Consensus on Cardiopulmonary Resuscitation Science with Treatment Recommendations. This section provides guidelines on the prevention of and ALS treatments for both in-hospital cardiac arrest and out-of-hospital cardiac arrest.

AdultResuscitationConsensusCardiac arrest; resuscitation; comamedicine.medical_treatment[SDV]Life Sciences [q-bio]ResuscitationeducationMEDLINE030204 cardiovascular system & hematologyEmergency Nursing03 medical and health sciences0302 clinical medicineSettore MED/41 - ANESTESIOLOGIAmedicineHumansCardiopulmonary resuscitationComaComputingMilieux_MISCELLANEOUSbusiness.industry030208 emergency & critical care medicinemedicine.diseaseCardiac arrestPrognosisCardiopulmonary Resuscitation3. Good healthAdvanced life supportEmergency MedicineMedical emergencyCardiology and Cardiovascular MedicinebusinessOut-of-Hospital Cardiac ArrestResuscitation
researchProduct

Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients

2016

Background Invasive fungal infections are important causes of morbidity and mortality among critically ill patients. Early institution of antifungal therapy is pivotal for mortality reduction. Starting a targeted antifungal therapy after culture positivity and fungi identification requires a long time. Therefore, alternative strategies (globally defined as 'untargeted antifungal treatments') for antifungal therapy institution in patients without proven microbiological evidence of fungal infections have been discussed by international guidelines. This review was originally published in 2006 and updated in 2016. This updated review provides additional evidence for the clinician dealing with s…

Adultmedicine.medical_specialtyAntifungal drugMycoseintensive care medicinelaw.invention03 medical and health sciencesImmunocompromised Hostcritically ill patient0302 clinical medicineRandomized controlled triallawInternal medicineAmphotericin BmedicineHumansAntifungal AgentPharmacology (medical)030212 general & internal medicineMED/41 - ANESTESIOLOGIAIntensive care medicineFluconazoleFluconazole [therapeutic use]Randomized Controlled Trials as Topicbusiness.industryfungal infectionMicafungin030208 emergency & critical care medicinePublication biasMycoses [mortalityClinical trialCritical Illness [mortality]; Amphotericin B [therapeutic use]; Antifungal Agents [therapeutic use]; Fluconazole [therapeutic use]; Immunocompromised Host; Mycoses [mortality; prevention & control]; Randomized Controlled Trials as Topic; Adult; HumansAntifungal Agents [therapeutic use]prevention & control]Relative riskMeta-analysisAmphotericin B [therapeutic use]AnidulafunginCritical IllneCritical Illness [mortality]businessmedicine.drugHuman
researchProduct

Pharmacological management of cancer pain in children

2014

The aim of this review was to assess cancer pain management in children on the basis of research published in the last ten years. Nine were papers providing clinical data, with a minimum of ten patients. No controlled studies were found. Regardless of general principles and existing recommendations, clinical data should confirm the applicability of this concept. The trials published in the last years did not provide further information to improve cancer pain management in children, because of the experience and the low number of drugs used, reflecting only meaningful opinions of experts in the field. The amount and the quality of data still remain poor, as only 737 subjects (about 80 patien…

Analgesicsmedicine.medical_specialtybusiness.industryCancer pain Pediatric painBreakthrough PainPharmacological managementAlternative medicinePainSettore MED/41 - AnestesiologiaHematologyPharmacologyClinical trialOncologyOpioidNeoplasmsHumansMedicineChildbusinessAdverse effectOpioid analgesicsIntensive care medicineCancer painmedicine.drug
researchProduct

Low dosage liposomal amphotericin B in the treatment of Candida infections in critically ill patients.

2011

Antifungal AgentsTreatment OutcomeCritical care candida sepsisAmphotericin BCritical IllnessCandidiasisHumansSettore MED/41 - AnestesiologiaPilot ProjectsAmphotericin B; administration /&/ dosage Antifungal Agents; administration /&/ dosage Candidiasis; drug therapy Critical Illness Humans Middle Aged Pilot Projects Treatment OutcomeMiddle Agedadministration /&/ dosagedrug therapy
researchProduct

Lessons from uncertainty on antifungal treatment in ICU

2017

We read with great interest the Editorial from Moghnieh et al. on the EMPIRICUS trial and antifungal use in intensive care unit (ICU) (1). Authors described nicely the trial and some background evidence on untargeted antifungal treatment in non-neutropenic critically ill patients in ICU (2,3). However, we believe that some points may be further clarified. First, it may be useful to cite the study from Knitsch et al. among those evaluating empiric antifungal treatment in ICU (4). Knitsch et al. enrolled 252 critically ill patients with localized/generalized intra-abdominal infection either of community or of nosocomial origin requiring emergency surgery.

AntifungalPulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryCritically illmedicine.drug_classMEDLINE030208 emergency & critical care medicinesepsis fungal infectionIntensive care unitlaw.invention03 medical and health sciences0302 clinical medicineEditorialEmergency surgerylawMedicineCommunity or030212 general & internal medicineMED/41 - ANESTESIOLOGIAbusinessIntensive care medicineLetter to the Editor
researchProduct

Untargeted Antifungal Treatment Strategies for Invasive Candidiasis in Non-neutropenic Critically Ill Patients: Current Evidence and Insights

2017

Purpose of Review: The purpose of this study was to provide an overview and insights on important new concepts on untargeted antifungal treatment strategies, namely prophylaxis pre-emptive and empiric treatments for the management of invasive candidiasis (IC) in non-neutropenic critically ill patients. Recent Findings: Recently, clinical practice guidelines provided recommendation for the management of IC. However, results from recent trials and systematic reviews questioned the effect of untargeted antifungal treatment strategies, especially in terms of survival benefits in non-neutropenic patients, even with septic shock. Summary: Widespread use of untargeted antifungal treatment strategi…

Antifungalmedicine.medical_specialtyEmpiric treatmentmedicine.drug_classInvasive candidiasiBiology03 medical and health sciences0302 clinical medicineInvasive fungal infectionmedicine030212 general & internal medicineAntifungal treatmentMED/41 - ANESTESIOLOGIAIntensive care medicineCandida infectionCritically illCandidemia030208 emergency & critical care medicineInvasive candidiasismedicine.diseaseNon neutropenicClinical PracticeInvasive candidiasisInfectious DiseasesSystematic reviewTreatment strategyAntifungal treatment; Candida infection; Candidemia; Empiric treatment; Invasive candidiasis; Invasive fungal infectionEmpiric treatment
researchProduct

CAUSE DI OLIGOANALGESIA IN AREA D’EMERGENZA AL TEMPO DELLE GRANDI IMMIGRAZIONI

2013

Obiettivo. L’AOU Policlinico di Palermo ha un centro dedi- cato ai bisogni sanitari degli immigrati regolari e clandestini, pertanto l’area di emergenza (PS) è il punto di riferimento di questa popolazione straniera. Il dolore, causa principale di accesso al PS, è sottotrattato. Le ipotesi delle differenze nella qualità del sollievo sono svariate, e comprendono anche etnia, razza, sesso ed età. Anche il modo in cui pazienti, di culture differenti, esprimono il proprio dolore e le interazioni tra medici e pazienti di diversa origine etnica possono influenza- re la valutazione. Abbiamo cercato di determinare se il sollie- vo dal dolore in PS è associato negativamente con la percezio- ne del m…

Area d'Emergenza Isolinguismo OligoanalgesiaSettore MED/41 - Anestesiologia
researchProduct

Le Reazioni da Mezzo di Contrasto: Il Trattamento.

2009

BLSmdcSettore MED/41 - Anestesiologia
researchProduct

Use of CD64 for the diagnosis of sepsis: a case-control study.

2010

CD64 is the high-affinity receptor of IgG. It is upregulated by inflammatory cytokines on neutrophils. The upregulation of CD64 is linked with PMN activation in SIRS or sepsis. Our aim is to verify these correlations.

CD64business.industryCase-control studySettore MED/41 - AnestesiologiaCritical Care and Intensive Care MedicineBioinformaticsmedicine.diseaseProinflammatory cytokineSepsisDownregulation and upregulationSepsisPoster PresentationImmunologyMedicineCD64SOFA scoreLinear correlationbusinessReceptor
researchProduct